Takeda Pharmaceutical (TKPHF) Exchange Rate Effect (2018 - 2026)

Takeda Pharmaceutical's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect rose 111.02% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $226.7 million (up 374.5% YoY), while the FY2026 annual figure was $229.0 million, up 406.4% from the prior year.
• Exchange Rate Effect was $7.0 million for Q1 2026 at Takeda Pharmaceutical, down from $145.8 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $173.9 million in Q2 2022 to a low of -$280.1 million in Q3 2024.
• Historically, Exchange Rate Effect has averaged $39.6 million across 5 years, with a median of $71.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect soared 10358.94% in 2022, then tumbled 1111.37% in 2024.
• A 5-year view of Exchange Rate Effect shows it stood at -$67.8 million in 2022, then jumped by 68.92% to -$21.1 million in 2023, then soared by 814.13% to $150.5 million in 2024, then declined by 3.09% to $145.8 million in 2025, then sank by 95.19% to $7.0 million in 2026.
• The last three Exchange Rate Effect figures came in at $7.0 million (Q1 2026), $145.8 million (Q4 2025), and $90.7 million (Q3 2025), per Business Quant data.